Session 1: Modeling public health impact and cost-effectiveness of the R21/Matrix-M malaria vaccine
Session 2: Meta-analysis of economic evaluations of vaccines
Session 3: Global analysis estimating the impact of vaccination over 50 years
Session 4: Modeling the impact of different dose schedules for RTS,S malaria vaccine in seasonal settings
Meeting material